Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Randomized Phase III Study of Neoadjuvant Chemotherapy followed by Surgery versus Surgery Alone for Patients with High Risk Retroperitoneal Sarcoma STRASS2
Study Type: Treatment
Phase: III
NCTID: NCT04031677
Principal Investigator:
Luke Selby
EXActDNA-003: Breast Cancer Clinical Validation Study to Predict Recurrence of High-Risk Early Breast Cancer Treated with Neoadjuvant Therapy Using a Bespoke Circulating Tumor DNA Assay to Detect Molecular Residual Disease NSABP B-64
Study Type: Other
Phase: N/A
NCTID: NCT06401421
Principal Investigator:
Julia White
Comparing Oral Drug Dosing Strategies in Older Patients with Metastatic Breast Cancer to Maximize Tolerance and Reduce Discontinuation: The CDK4/6 Inhibitor Dosing Knowledge CDK Study
Study Type: Treatment
Phase: III
NCTID: NCT06377852
Principal Investigator:
Ryan Rader
A Phase III, Multicenter, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA IT PET/CT in Staging of Men with Newly Diagnosed Unfavorable Intermediate-risk, High-risk or Very High-risk Prostate Cancer Electing to Undergo Radical Prostatectomy with Pelvic Lymph Node Dissection
Study Type: Diagnostic
Phase: III
NCTID: NCT06235151
Principal Investigator:
William Parker
A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer Lung-MAP Screening Study
Study Type: Screening
Phase: III
NCTID: NCT03851445
Principal Investigator:
Anusha Chidharla
A Phase III, Randomized Study of Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone Dara-VCD Induction Followed by Autologous Stem Cell Transplant or Dara-VCD Consolidation and Daratumumab Maintenance in Patients with Newly Diagnosed AL Amyloidosis
Study Type: Treatment
Phase: III
NCTID: NCT06022939
Principal Investigator:
Muhammad Umair Mushtaq
Randomized Phase II/III Trial of 2nd Line Nivolumab + Paclitaxel + Ramucirumab versus Paclitaxel + Ramucirumab in Patients with PD-L1 CPS ? 1 Advanced Gastric and Esophageal Adenocarcinoma PARAMUNE
Study Type: Treatment
Phase: II/III
NCTID: NCT06203600
Principal Investigator:
Gary Doolittle
A Randomized Controlled Trial using a Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults with Cancer
Study Type: Supportive Care
Phase: N/A
NCTID: NCT05958316
Principal Investigator:
Kristin Stegenga
A Randomized Phase II Study of CHOEP vs CC-486- CHOEP vs duvelisib- CHOEP in previously Untreated CD30 Negative Peripheral T-cell Lymphomas
Study Type: Treatment
Phase: II
NCTID: NCT04803201
Principal Investigator:
Marc Hoffmann
Using Microbiome to Predict Durvalumab Toxicity in Post-CCRT NSCLC Patients MicroDurva
Study Type: Basic Science
Phase: IV
NCTID: NCT04680377
Principal Investigator:
Chao Huang